about
Antidepressants for the treatment of depression in people with cancerAntidepressants for the treatment of depression in patients with cancerThe impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysisThe prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysisA systematic review of anxiety amongst people with Multiple Sclerosis.The Relationship Between Mental Health, Disease Severity and Genetic Risk for Depression in Early Rheumatoid ArthritisA Systematic Review and Meta-Analysis of e-Mental Health Interventions to Treat Symptoms of Posttraumatic Stress.Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study.Usefulness of the SF-36 Health Survey in screening for depressive and anxiety disorders in rheumatoid arthritis.Smoking and common mental disorders in patients with chronic conditions: An analysis of data collected via a web-based screening system.Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized controlled trialDepression in patients with chronic pain attending a specialised pain treatment centre: prevalence and impact on health care costsSelf-help interventions for symptoms of depression, anxiety and psychological distress in patients with physical illnesses: a systematic review and meta-analysis.Psychological correlates of fatigue in rheumatoid arthritis: a systematic review.The prevalence of diabetes mellitus and abnormal glucose metabolism in the inpatient psychiatric setting: A systematic review and meta-analysis.Mental disorder in limb reconstruction: Prevalence, associations and impact on work disability.Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting.A pilot randomized controlled trial to increase smoking cessation by maintaining National Health Service Stop Smoking Service attendance.Liver transplantation and adolescence: The role of mental health.Fatigue and psychosocial variables in autoimmune rheumatic disease and chronic fatigue syndrome: A cross-sectional comparison.Embedding integrated mental health assessment and management in general hospital settings: feasibility, acceptability and the prevalence of common mental disorder.The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis: reply.The relationship between depression and biologic treatment response in rheumatoid arthritis: An analysis of the British Society for Rheumatology Biologics Register.Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial.Barriers to and Facilitators of Engagement With Remote Measurement Technology for Managing Health: Systematic Review and Content Analysis of FindingsThe Impact of Targeted Rheumatoid Arthritis Pharmacologic Treatment on Mental HealthMobile apps, wearables and the future of technology in rheumatic disease careBarriers to and Facilitators of Engagement With Remote Measurement Technology for Managing Health: Systematic Review and Content Analysis of Findings (Preprint)Letter to the editor: The impact of targeted rheumatoid arthritis pharmacologic treatment on mental health: A systematic review and meta-analysis: ReplyBarriers to and Facilitators of Engagement With mHealth Technology for Remote Measurement and Management of Depression: Qualitative AnalysisRemote assessment of disease and relapse in major depressive disorder (RADAR-MDD): a multi-centre prospective cohort study protocolCommon mental disorders within chronic inflammatory disorders: a primary care database prospective investigationHuman-Centered Design Strategies for Device Selection in mHealth Programs: Development of a Novel Framework and Case StudyPatients' Measurement Priorities for Remote Measurement Technologies to Aid Chronic Health Conditions: Qualitative Analysis
P50
Q24187358-8EDC9989-1202-4058-B855-596819565425Q24198949-4C1BC813-6DAC-40D9-ACB5-E1B9B65A6F1FQ26851432-B487FF5C-5B4C-4F6E-A70A-3A48E93AC767Q27022403-2E1014FF-35DF-4983-AB75-3D0EEF4B522BQ30240304-CF562B37-0426-463D-ADC7-330C6F5E3981Q30491102-F98703C0-2F47-4B25-B7F4-F8E765366CF9Q33747660-39F8139D-1D1F-4941-89AF-0D988E44CA44Q35986521-BB3AC13A-AD6B-46C0-AED5-E956013E24DFQ36027103-51118A53-ACF2-46FE-923A-38E26B94B046Q36301331-8999CD63-EFC1-41D3-A8F6-F83C80A73EE6Q36456818-66DBF4F0-C616-4BA1-931C-065DBEFA8C4DQ37016589-F13E4399-1AB6-437A-8F7E-6C0688C7F543Q38186428-A3BF2735-2DE3-4EEA-BBB9-410C3FC50A5FQ38442585-EDB71062-8206-4065-B65B-1D7DE5235E83Q38920192-34D2BC49-24DF-4679-B21A-A8FA98B1074DQ39356868-81C90139-014E-4F1B-84FF-B91BAD6C005EQ39642015-7A468928-4611-4DB2-A550-97DF265C2AAEQ44192844-5159F8AB-6ACA-4168-BFFD-56DA7A8C3986Q47379857-71E9A884-15F7-4982-88F2-E5DE1B29FD46Q47781918-D772344F-D941-4F93-B4BC-EADB6BE58F3AQ48334321-D86154C0-3889-4893-88AD-5C920C4D0CC6Q48374491-51D6BDFC-8E60-437B-B360-A49DA695402DQ49977837-6E8AE2A5-C1B3-42C2-9A03-C39F296E7919Q55223606-D142AC25-0938-494D-8133-562366F1795FQ57176295-30F4CA6C-6BC6-4667-941F-721B599F71AFQ58220869-E3488555-62BF-4019-B253-82C25048D870Q60706205-8AB8C4EB-4062-47A5-854A-0AC726A0E193Q60706210-ADC85909-D3A0-4EAF-8443-D0A1F7D65625Q61633710-99827440-0DBF-4336-9F6E-8BAE6D56EAF6Q64238953-E569DF73-DFD9-499B-8198-57E8D9FC56B0Q64254357-E58B5B48-B39F-4D53-AC86-D6CBAFEB9385Q92205102-43271279-BE37-4753-8970-49101B73EDDFQ94603683-2D318955-287C-4C5A-9950-542DE090FBA0Q96235482-CBDB7372-25B4-40C7-A49C-02B2464E3098
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Faith Matcham
@ast
Faith Matcham
@en
Faith Matcham
@es
Faith Matcham
@nl
Faith Matcham
@sl
type
label
Faith Matcham
@ast
Faith Matcham
@en
Faith Matcham
@es
Faith Matcham
@nl
Faith Matcham
@sl
prefLabel
Faith Matcham
@ast
Faith Matcham
@en
Faith Matcham
@es
Faith Matcham
@nl
Faith Matcham
@sl
P106
P1153
55930190900
P21
P31
P496
0000-0002-4055-904X
P569
2000-01-01T00:00:00Z